Antibiotics Manual

A Guide to commonly used antimicrobials
 
 
Standards Information Network (Verlag)
  • 2. Auflage
  • |
  • erschienen am 10. August 2017
  • |
  • 480 Seiten
 
E-Book | PDF mit Adobe-DRM | Systemvoraussetzungen
978-1-119-22077-0 (ISBN)
 
A comprehensive compendium of all commonly used antibiotics, including indications, side effects, dosage information, and drug/food interactions
The Antibiotics Manual: A Guide to Commonly Used Antimicrobials, Second Edition is a unique, user-friendly guide made for all who prescribe antibiotics. It's the only book available that takes a 100% drug-listed approach to 200 of the most common antibiotics prescribed to patients each day. Presented in full color, it's also a convenient reference for every clinician to consult once the decision to use a particular antibiotic has been reached.
This edition of The Antibiotics Manual includes newer antibiotics that have been released since the publication of the First Edition and updates prescribing information for the older antibiotics. This all-new Second Edition:
* Has a color-coded interior design which provides quick and easy point of care access for the user
* Includes 200 of the most commonly prescribed antibiotics, listed by both brand and generic names
* Features important recently-released antibiotics such as ceftaroline, tedizolid, and bedaquiline
The Antibiotics Manual: A Guide to Commonly Used Antimicrobials, Second Edition is a welcome book for physicians in all specialties of medicine who prescribe antibiotics. It is also a handy tool for pharmacists, nurses, nurse practitioners, and physician assistants who want more information on the drugs they administer.
2. Auflage
  • Englisch
  • Newark
  • |
  • Großbritannien
John Wiley & Sons Inc
  • Für Beruf und Forschung
  • Überarbeitete Ausgabe
  • 4,26 MB
978-1-119-22077-0 (9781119220770)
weitere Ausgaben werden ermittelt
DAVID SCHLOSSBER, MD, FACP, FIDSA, FCPP, The Lewis Katz School of Medicine at Temple University, Philadelphia, USA
RAFIK SAMUEL, MD, FACP, FIDSA, FCPP, The Lewis Katz School of Medicine at Temple University, Philadelphia, USA
  • Intro
  • TITLE PAGE
  • COPYRIGHT PAGE
  • BRAND TABLE OF CONTENTS
  • GENERIC NAME
  • PREFACE
  • ■ ABELCET (Amphotericin B Lipid Complex)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC IMPAIRMENT
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ALBENZA (Albendazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ALINIA (Nitazoxanide)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AMBISOME (Liposomal Amphotericin B)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC IMPAIRMENT
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AMIKIN (Amikacin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AMOXICILLIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AMPHOTEC (Amphotericin B Colloidal Dispersion - ABCD)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC IMPAIRMENT
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AMPICILLIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ANCEF (Cefazolin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ANCOBON (Flucytosine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • HEPATIC IMPAIRMENT
  • RENAL IMPAIRMENT
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ANTIMINTH (Pyrantel Pamoate)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ARALEN (Chloroquine Phosphate and Hydroxychloroquine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ARTESUNATE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ATABRINE (Quinacrine HCl)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ATRIPLA (Tenofovir/Emtricitabine/Efavirenz)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AUGMENTIN, AUGMENTIN 600ES, AUGMENTIN XR (Amoxicillin-Clavulanate Potassium)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AVELOX (Moxifloxacin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AVYCAZ (Ceftazidime and Avibactam Sodium Powder)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • GERIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ AZACTAM (Aztreonam)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYNFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BACTRIM, BACTRIM DS, SEPTRA, SEPTRA DS (Trimethoprim/Sulfamethoxazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BARACLUDE (Entecavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BENZATHINE PENICILLIN, PENICILLIN G, PENICILLIN V, PROCAINE PENICILLIN (Penicillin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BENZNIDAZOLE
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BIAXIN (Clarithromycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BILTRICIDE (Praziquantel)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BITIN (Bithionol)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ BROACT, CEFROM KEITEN, CEFIR (Cefpirome)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CANCIDAS (Caspofungin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT
  • HEPATIC DYSFUNCTION
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CAPASTAT (Capreomycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CEDAX (Ceftibuten)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CEFACLOR
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CEFIZOX (Ceftizoxime)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CEFOTAN (Cefotetan)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CEFTIN (Cefuroxime Axetil), ZINACEF (Cefuroxime)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CEFZIL (Cefprozil)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CHLOROMYCETIN (Chloramphenicol)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CHLOROQUINE PHOSPHATE (Aralen), HYDROXYCHLOROQUINE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CIPRO (Ciprofloxacin), CIPRO XR
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CLAFORAN (Cefotaxime)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CLEOCIN (Clindamycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ COARTEM (Artemether/Lumefantrine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ COLY-MYCIN® M PARENTERAL
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ COLY-MYCIN (Colistimethate Sodium)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ COMBIVIR (Zidovudine plus Lamivudine)
  • BASIC CHARACTERISTICS
  • FDA-APROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ COMPLERA (Tenofovir + Emtricitabine + Rilpivirine)
  • BASIC CHACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY:
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: for treatment:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ COPEGUS, REBETOL, RIBASPHERE (Ribavirin Oral)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • Adult use
  • Pediatric use
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CRESEMBA (Isavuconazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRIC:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CUBICIN (Daptomycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ CYTOVENE (Ganciclovir Capsules and IV)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DAKLINZA (Daclatasvir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DALVANCE (Dalbavancin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DAPSONE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DARAPRIM (Pyrimethamine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DELTYBA (Delamanid)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DESCOVY (Tenofovir Alafenamide?+?Emtricitabine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DICLOXACILLIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DIFICID (Fidaxomicin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DIFLUCAN (Fluconazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DORIBAX (Doripenem)
  • BASIC CHARACTERISTICS
  • FDA-APROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DORYX (Doxycycline Delayed Release), VIBRAMYCIN (Doxycycline)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: For children above eight years of age:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DURICEF (Cefadroxil)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ DYNACIN (Minocycline Tablets), MINOCIN (Minocycline Capsules)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ EDURANT (Rilpivirine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: for treatment:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ Emtriva (Emtricitabine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ EPCLUSA (Sofosbuvir?+?Velpatasvir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ EPIVIR (Lamivudine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ EPZICOM (Lamivudine plus Abacavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ERAXIS (Anidulafungin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ERYTHROMYCIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ EVOTAZ (Atazanavir?+?Cobicistat)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FACTIVE (Gemifloxacin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FAMVIR (Famciclovir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRIC:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FLAGYL (Metronidazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FLOXIN (Ofloxacin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FORTAZ (Ceftazidime), TAZICEF
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FOSCAVIR (Foscarnet)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING (BY CONTROLLED INFUSION)
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FUNGIZONE (Amphotericin B)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FURADANTIN, MACROBID, MACRODANTIN (Nitrofurantoin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ FUZEON (Enfuvirtide)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ GARAMYCIN (Gentamicin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ GENVOYA (Tenofovir Alafenamide?+?Emtricitabine?+?Elvitegravir?+?Cobicistat)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ GERMANIN (Suramin sodium)
  • BASIC CHARACTERIZATION
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ GLUCANTIME (Meglumine Antimonite)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ GRIFULVIN V, GRIS-PEG (Griseofulvin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ HARVONI (Ledipasvir?+?Sofosbuvir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ HEPSERA (Adefovir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ HETRAZAN (Diethyl Carbamazine/DEC)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ IMPAVIDO (Miltefosine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ INFERGEN (Interferon Alpha)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ INTELENCE (Etravirine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: for treatment:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ INTRON A (Interferon Alpha)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ INVANZ (Ertapenem)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • Pediatrics:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ISENTRESS (Raltegravir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ISONIAZID
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING (dose should never be divided, but should be given as a single dose)
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ KALETRA (Lopinavir/Ritonavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ KANTREX (Kanamycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ KEFLEX (Cephalexin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ KETOCONAZOLE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/ADMINISTRATION
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ LAMISIL (Terbinafine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ LAMPIT (Nifurtimox)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ LAMPRENE (Clofazimine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ Lariam (Mefloquine Hydrochloride)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ LEVAQUIN (Levofloxacin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ LEXIVA (Fosamprenavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MALARONE (Atovaquone/Proguanil)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MANDOL (Cefamandole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MAXIPIME (Cefepime)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MEFOXIN (Cefoxitin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MEL-B (Melarsoprol B)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MEPRON (Atovaquone)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MERREM (Meropenem)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MINTEZOLE (Thiabendazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MONUROL (Fosfomycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MYAMBUTOL (Ethambutol Hydrochloride)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING (dose should never be divided, but should be given as a single dose)
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MYCAMINE (Micafungin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • Pediatrics:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ MYCOBUTIN (Rifabutin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ NAFCILLIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ NEBUPENT, PENTAM (Pentamidine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ NEO-FRADIN, NEOMYCIN (Neomycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ NORVIR (Ritonavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ NOXAFIL (Posaconazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/ADMINISTRATION
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ODEFSEY (Tenofovir alafenamide?+?Emtricitabine?+?Rilpivirine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: for treatment:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ OLYSIO (Simeprevir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ OMNICEF (Cefdinir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ORBACTIVE (Oritavancin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ORNIDYL (Eflornithine)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ OXACILLIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PASER (Para-aminosalicylate Sodium)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PEGASYS (Peginterferon alpha-2a)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PEGINTRON (Peginterferon alpha-2b)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PENTOSTAM (Stibogluconate)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PIPRACIL (Piperacillin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • RENAL AND HEPATIC FAILURE:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ POLYMyXIN B Injection (Polymyxin B Sulfate)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING (1?mg?=?10 000 units)
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PREZCOBIX (Darunavir?+?Cobicistat)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PREZISTA (Darunavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PRIFTIN (Rifapentine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PRIMAQUINE (Primaquine Phosphate)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PRIMAXIN (Imipenem-Cilastatin Sodium)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PROLOPRIM (Trimethoprim)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ PYRAZINAMIDE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ QUINIDINE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ QUININE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ RAPIVAB (Peramivir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ RELENZA (Zanamivir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ RETROVIR (Zidovudine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ REYATAZ (Atazanavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ RIFADIN, RIFADIN IV (Rifampin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ RIFAMATE (Rifampin?+?Isoniazid)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ RIFATER (Rifampin?+?Isoniazid?+?Pyrazinamide)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ROCEPHIN (Ceftriaxone)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ROVAMYCINE (Spiramycin)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SELZENTRY (Maraviroc)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SEROMYCIN (Cycloserine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SIRTURO (Bedaquiline)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SIVEXTRO (Tedizolid)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SOVALDI (Sofosbuvir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SPECTRACEF (Cefditoren pivoxil)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SPORANOX (Itraconazole) (capsules and solution)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/ADMINISTRATION
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ STREPTOMYCIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ STRIBILD (Tenofovir?+?Emtricitabine?+?Elvitegravir?+?Cobicistat)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ STROMECTOL (Ivermectin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SULFADIAZINE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • RENAL AND HEPATIC FAILURE:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SUPRAX (Cefixime)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ SUSTIVA (Efavirenz)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TAMIFLU (Oseltamivir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRIC:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TECHNIVIE (Ombitasvir?+?Paritaprevir?+?Ritonavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TEFLARO (Ceftaroline Fosamil)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • Pediatrics:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TETRACYCLINE HYDROCHLORIDE
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: For children above eight years of age:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TIGACYL (Tigecycline)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TIMENTIN (Ticarcillin Disodium-Clavulanate Potassium)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TINDAMAX (Tinidazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TIVICAY (Dolutegravir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TOBRAMYCIN
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TRECATOR (Ethionamide)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TRIUMEQ (Abacavir?+?Lamivudine?+?Dolutegravir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TRIZIVIR (Zidovudine, Lamivudine, and Abacavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENTS:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TROBICIN (Spectinomycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • Pediatrics:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TRUVADA (Tenofovir and Emtricitabine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TYBOST (Cobicistat)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ TYZEKA (Telbivudine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ Unasyn (Ampicillin Sodium-Sulbactam Sodium)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VALCYTE (Valganciclovir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VALTREX (Valacyclovir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VANCOCIN (Vancomycin-PO)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ Vancomycin-(Intravenous Only)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VANSIL (Oxamniquine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VANTIN (Cefpodoxime)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING (PO)
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VEMLIDY (Tenofovir Alafenamide Fumarate (TAF))
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VFEND (Voriconazole)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/ADMINISTRATION
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VIBATIV (Telavancin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VIEKIRA PAK (Dasabuvir + Ombitasvir + Paritaprevir + Ritonavir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VIRAMUNE (Nevirapine)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS: for treatment:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VIRAZOLE (Ribavirin Inhaled)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • Pediatrics:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VIREAD (Tenofovir Disoproxil Fumarate)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VISTIDE (Cidofovir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ VITEKTA (Elvitegravir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ XIFAXAN (Rifaximin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ YODOXIN (Iodoquinol)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION (not due to amebiasis):
  • Pediatrics:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ YOMESAN (Niclosamide)
  • BASIC CHARACTERISTICS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ZEPATIER (Elbasvir and Grazoprevir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ZERBAXA (Ceftolozane and Tazobactam)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL INPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • GERIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ZIAGEN (ABACAVIR)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ Zithromax, ZMAX (Azithromycin)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ Zosyn (Piperacillin-Tazobactam)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ZOVIRAX (Acyclovir)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • ■ ZYVOX (Linezolid)
  • BASIC CHARACTERISTICS
  • FDA-APPROVED INDICATIONS
  • SIDE EFFECTS/TOXICITY
  • DRUG INTERACTIONS/FOOD INTERACTIONS
  • DOSING
  • SPECIAL POPULATIONS
  • RENAL IMPAIRMENT:
  • HEPATIC DYSFUNCTION:
  • PEDIATRICS:
  • THE ART OF ANTIMICROBIAL THERAPY
  • Selected Antimicrobial Coverage
  • Bibliography and References
  • EULA

Dateiformat: PDF
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Bitte beachten Sie bei der Verwendung der Lese-Software Adobe Digital Editions: wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

Weitere Informationen finden Sie in unserer E-Book Hilfe.


Download (sofort verfügbar)

68,99 €
inkl. 7% MwSt.
Download / Einzel-Lizenz
PDF mit Adobe-DRM
siehe Systemvoraussetzungen
E-Book bestellen